Showing results (481-490 of 105,986) with videos related to
Sort By:
Pageof 10,599
Journal of Medicinal Chemistry|August 1, 1980
Inhibitors of phenylethanolamine N-methyltransferase and epinephrine biosynthesis. 2. 1,2,3,4-Tetrahydroisoquinoline-7-sulfonanilidesB Blank, A J Krog, G Weiner, et al.The Annals of Pharmacotherapy|February 6, 2009
Comparison of 2002-2006 OPTAMA programs for US hospitals: focus on gram-negative resistanceJared L Crandon, Joseph L Kuti, Ronald N Jones, et al.Diagnostic Microbiology and Infectious Disease|June 9, 2004
Pharmacodynamic comparisons of antimicrobials against nosocomial isolates of escherichia coli, klebsiella pneumoniae, acinetobacter baumannii and pseudomonas aeruginosa from the MYSTIC surveillance program: the OPTAMA Program, South America 2002Carlos R V Kiffer, Caio Mendes, Joseph L Kuti, et al.Pharmacotherapy|January 27, 2004
Pharmacodynamics of meropenem and imipenem against Enterobacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosaJoseph L Kuti, Naomi R Florea, Charles H Nightingale, et al.Clinical Therapeutics|March 7, 2020
Assessment of Meropenem and Vaborbactam Room Temperature and Refrigerated Stability in Polyvinyl Chloride Bags and Elastomeric DevicesIris H Chen, Elizabeth K Martin, David P Nicolau, et al.Pharmacotherapy|January 12, 2013
Inappropriate antibiotic use due to decreased compliance with a ventilator-associated pneumonia computerized clinical pathway: implications for continuing education and prospective feedbackAshley M Wilde, Michael D Nailor, David P Nicolau, et al.Annals of Clinical Microbiology and Antimicrobials|January 20, 2021
Contemporary analysis of ETEST for antibiotic susceptibility and minimum inhibitory concentration agreement against Pseudomonas aeruginosa from patients with cystic fibrosisMaxwell J Lasko, Holly K Huse, David P Nicolau, et al.Clinical Pharmacokinetics|October 19, 2016
Clinical Determinants of Target Non-Attainment of Linezolid in Plasma and Interstitial Space Fluid: A Pooled Population Pharmacokinetic Analysis with Focus on Critically Ill PatientsIris K Minichmayr, André Schaeftlein, Joseph L Kuti, et al.The Journal of Antimicrobial Chemotherapy|July 30, 2022
Imipenem/cilastatin/relebactam pharmacokinetics in critically ill patients with augmented renal clearanceAndrew J Fratoni, John W Mah, David P Nicolau, et al.American Journal of Surgery|October 21, 2020
A multi-institutional study of patient-derived gender-based discrimination experienced by resident physiciansAnna Alaska Pendleton, Sophia K McKinley, Virginia E Pendleton, et al.Pageof 10,599